.
  • NIFTY 25,424.65 -288.35 (-1.12%)
  • SENSEX 82,225.92 -1,068.74 (-1.28%)
BSE
NSE

Tuesday, February 24, 2026 , BSE Sensex : 82,225.92 82,225.92(-1.28%) , Adani Ports : 1,555.25 1,555.25(-0.08%) , Asian Paints : 2,413.25 2,413.25(-0.64%) , Axis Bank : 1,387.65 1,387.65(0.08%) , Bajaj Finance : 1,023.80 1,023.80(-0.70%) , Bajaj Finserv : 2,046.05 2,046.05(-0.24%) , Bharat Electron : 435.00 435.00(-1.07%) , Bharti Airtel : 1,940.70 1,940.70(-2.83%) , Eternal : 253.95 253.95(-5.28%) , HCL Technologies : 1,339.40 1,339.40(-6.10%) , HDFC Bank : 910.70 910.70(-1.42%) , Hind. Unilever : 2,359.30 2,359.30(0.62%) , ICICI Bank : 1,384.80 1,384.80(-1.02%) , Infosys : 1,276.55 1,276.55(-3.91%) , Interglobe Aviat : 4,850.20 4,850.20(-0.23%) , ITC : 323.55 323.55(-0.55%) , Kotak Mah. Bank : 427.60 427.60(-0.72%) , Larsen & Toubro : 4,258.50 4,258.50(-3.59%) , M & M : 3,429.90 3,429.90(-0.44%) , Maruti Suzuki : 14,924.40 14,924.40(-0.95%) , NTPC : 382.75 382.75(1.94%) , Power Grid Corpn : 304.85 304.85(0.49%) , Reliance Industries : 1,430.15 1,430.15(0.16%) , SBI : 1,223.85 1,223.85(-0.32%) , Sun Pharma.Inds. : 1,730.55 1,730.55(-0.10%) , Tata Steel : 209.15 209.15(0.53%) , TCS : 2,574.50 2,574.50(-3.79%) , Tech Mahindra : 1,346.55 1,346.55(-6.60%) , Titan Company : 4,294.20 4,294.20(0.51%) , Trent : 3,934.65 3,934.65(-2.93%) , UltraTech Cem. : 12,951.50 12,951.50(-0.18%) ,

Nifty 50 : 25,424.65 -288.35(-1.12%) , Adani Enterp. : 2,183.00 -8.00(-0.37%) , Adani Ports : 1,555.40 -0.40(-0.03%) , Apollo Hospitals : 7,720.50 27.50(0.36%) , Asian Paints : 2,413.10 -16.60(-0.68%) , Axis Bank : 1,387.60 0.90(0.06%) , Bajaj Auto : 9,829.00 -76.50(-0.77%) , Bajaj Finance : 1,023.55 -7.45(-0.72%) , Bajaj Finserv : 2,043.30 -8.30(-0.40%) , Bharat Electron : 435.05 -4.70(-1.07%) , Bharti Airtel : 1,941.00 -56.30(-2.82%) , Cipla : 1,326.70 0.20(0.02%) , Coal India : 430.95 4.95(1.16%) , Dr Reddy's Labs : 1,300.20 -7.20(-0.55%) , Eicher Motors : 7,929.00 -109.50(-1.36%) , Eternal : 254.00 -14.00(-5.22%) , Grasim Inds : 2,879.30 5.90(0.21%) , HCL Technologies : 1,339.20 -87.00(-6.10%) , HDFC Bank : 910.50 -13.10(-1.42%) , HDFC Life Insur. : 734.75 -7.70(-1.04%) , Hind. Unilever : 2,358.60 13.20(0.56%) , Hindalco Inds. : 922.85 6.65(0.73%) , ICICI Bank : 1,384.80 -14.60(-1.04%) , Infosys : 1,275.50 -52.00(-3.92%) , Interglobe Aviat : 4,850.30 -11.90(-0.24%) , ITC : 323.50 -1.90(-0.58%) , Jio Financial : 255.25 -2.55(-0.99%) , JSW Steel : 1,254.50 14.00(1.13%) , Kotak Mah. Bank : 427.70 -3.00(-0.70%) , Larsen & Toubro : 4,259.20 -158.90(-3.60%) , M & M : 3,433.20 -13.90(-0.40%) , Maruti Suzuki : 14,926.00 -146.00(-0.97%) , Max Healthcare : 1,086.40 2.80(0.26%) , Nestle India : 1,320.00 4.90(0.37%) , NTPC : 382.75 7.30(1.94%) , O N G C : 276.50 0.85(0.31%) , Power Grid Corpn : 304.80 1.45(0.48%) , Reliance Industries : 1,428.80 0.80(0.06%) , SBI : 1,223.30 -4.50(-0.37%) , SBI Life Insuran : 2,082.90 -26.70(-1.27%) , Shriram Finance : 1,061.70 -3.00(-0.28%) , Sun Pharma.Inds. : 1,731.80 -0.50(-0.03%) , Tata Consumer : 1,178.00 6.20(0.53%) , Tata Motors PVeh : 377.55 -2.40(-0.63%) , Tata Steel : 209.13 0.99(0.48%) , TCS : 2,573.70 -102.60(-3.83%) , Tech Mahindra : 1,345.40 -95.50(-6.63%) , Titan Company : 4,294.50 21.80(0.51%) , Trent : 3,931.30 -123.60(-3.05%) , UltraTech Cem. : 12,960.00 -16.00(-0.12%) , Wipro : 200.14 -5.75(-2.79%) , Tuesday, February 24, 2026

Home >> Markets >> Equities >> News - News Details
Hot Pursuit
24-Feb-2026     14:53
Alembic Pharma gets USFDA nod for antifungal ANDA
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jublia Topical Solution, 10%, of Bausch Health Americas, Inc. (Bausch). The said drug is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes.

According to IQVIA, Efinaconazole Topical Solution, 10%, has an estimated market size of $500 million for twelve months ending December 2025.

The company has a cumulative total of 234 ANDA approvals (215 final approvals and 19 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development company, is engaged in the manufacture and marketing of generic pharmaceutical products across global markets. The company's consolidated net profit fell 3.9% to Rs 132.97 crore despite a 10.8% jump in net sales to Rs 1,876.31 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.31% to Rs 757 on the BSE.

Powered by Capital Market - Live News